Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.420
-0.030 (-2.07%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Marker Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 24 | 25 | 33 | 49 | 23 | 79 | |
| Market Cap Growth | 115.23% | -25.40% | -31.89% | 115.29% | -71.23% | 13.36% | |
| Enterprise Value | 8 | 7 | 24 | 31 | 12 | 42 | |
| Last Close Price | 1.42 | 1.49 | 3.11 | 5.50 | 2.66 | 9.50 | |
| PS Ratio | 6.68 | 7.01 | 5.05 | 14.77 | 6.46 | 63.58 | |
| PB Ratio | 1.41 | 1.48 | 1.79 | 3.48 | 1.16 | 1.80 | |
| P/TBV Ratio | 1.41 | 1.48 | 1.79 | 3.48 | 1.16 | 1.80 | |
| EV/Sales Ratio | 2.15 | 2.05 | 3.69 | 9.49 | 3.52 | 34.02 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.27 | |
| Net Debt / Equity Ratio | -0.96 | -0.96 | -1.03 | -1.07 | -0.60 | -0.69 | |
| Net Debt / EBITDA Ratio | - | - | - | 1.28 | 0.69 | 0.82 | |
| Net Debt / FCF Ratio | 1.34 | 1.34 | 1.76 | 0.92 | 0.44 | 1.00 | |
| Asset Turnover | 0.17 | 0.17 | 0.34 | 0.13 | 0.07 | 0.02 | |
| Quick Ratio | 7.67 | 7.67 | 6.22 | 5.25 | 1.82 | 3.28 | |
| Current Ratio | 8.39 | 8.39 | 6.36 | 5.57 | 2.14 | 3.56 | |
| Return on Equity (ROE) | -68.81% | -68.81% | -65.81% | -83.47% | -62.20% | -117.42% | |
| Return on Assets (ROA) | -37.83% | -37.83% | -35.50% | -35.36% | -24.12% | -43.38% | |
| Return on Capital Employed (ROCE) | -74.00% | -74.00% | -59.90% | -103.80% | -74.30% | -71.50% | |
| Earnings Yield | -51.38% | -48.96% | -32.23% | -16.85% | -131.80% | -53.05% | |
| FCF Yield | -50.74% | -48.36% | -32.76% | -33.63% | -118.78% | -38.52% | |
| Buyback Yield / Dilution | -70.49% | -70.49% | -1.94% | -5.49% | -9.16% | -62.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.